News & Updates
February 2024
Matthias Koepp will give a talk on “Topiramate Intravenously” at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (Eilat XVII) in Madrid scheduled for May 5-8, 2024.
December 2023
Wolfgang Löscher will give a talk on “Treatment of neonatal seizures: New drugs in the pipeline” at the EpiCARE/ILAE meeting “In Search of Lost Time 4: Epilepsy Care Challenges From Neonates to Adults” in Rome scheduled for 13.-15. December 2023.
Special Announcement regarding AES 2023
Matthias Koepp will present at AES 2023 as part of the Special Lecture | Lombroso Lecture: “The Path to Personalized Treatments for Epilepsies – Translation, Biomarkers and the Role of the Community”
Pavel Klein will be presenting “Update on New Anti-epilepsy Treatments” as part of the 35th Advances in the Management of Epilepsy and the Epilepsy Clinic on Friday, December 1, 2023. He will also moderate a Satellite Symposium on “Drug Resistant Epilepsies” at AES 2023 (sponsored by SK Biopharmaceuticals Co)
September 2023
PrevEp receives NINDS SBIR award 1R43NS132659 titled “Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate”
October 2023
PrevEp team members Pavel Klein, Alex Rotenberg, Detlev Boison, and Matthias Koepp to participate at AES 2023 in Orlando/FL from December 1-5, 2023
October 2022
Matthias Koepp, M.D., joins the PrevEp team as VP, Product Development
January 2023
Meir Bialer, Ph.D., M.B.A. joins the PrevEp advisory board
September 2021
PrevEp receives NINDS SBIR award 1R43NS119081
May 2022
Alexander Kraus, Ph.D., joins the PrevEp team as Chief Business Development Officer